WallStreetZenWallStreetZen

NYSE: BLCO
Bausch & Lomb Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BLCO

Based on 5 analysts offering 12 month price targets for Bausch & Lomb Corp.
Min Forecast
$17.00-5.24%
Avg Forecast
$19.40+8.14%
Max Forecast
$22.00+22.63%

Should I buy or sell BLCO stock?

Based on 5 analysts offering ratings for Bausch & Lomb Corp.
Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 40%
Hold
3 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BLCO stock forecasts and price targets.

BLCO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 10%
10
BuyMaintains$22.00+22.63%2023-05-19
Barclays
Bottom 11%
11
HoldMaintains$18.00+0.33%2023-05-05
RBC Capital
Bottom 7%
7
BuyReiterates$20.00+11.48%2023-05-04
JP Morgan
Top 16%
85
HoldMaintains$17.00-5.24%2023-02-23
Morgan Stanley
Bottom 15%
15
HoldMaintains$20.00+11.48%2023-02-23

1 of 1

Forecast return on equity

Is BLCO forecast to generate an efficient return?
Company
7.77%
Industry
19.86%
Market
90.31%
BLCO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BLCO forecast to generate an efficient return on assets?
Company
4.86%
Industry
10.78%
BLCO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BLCO revenue growth forecast

How is BLCO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
3.85%
Industry
6.22%
Market
8.84%
BLCO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BLCO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BLCO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BLCO$17.94$19.40+8.14%Hold
NVST$33.27$45.00+35.26%Strong Buy
NVCR$73.56$88.80+20.72%Buy
XRAY$36.96$43.17+16.79%Buy
MMSI$81.44$85.17+4.58%Buy
View Top Medical Stocks

Bausch & Lomb Stock Forecast FAQ

Is Bausch & Lomb Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: BLCO) stock is to Hold BLCO stock.

Out of 5 analysts, 0 (0%) are recommending BLCO as a Strong Buy, 2 (40%) are recommending BLCO as a Buy, 3 (60%) are recommending BLCO as a Hold, 0 (0%) are recommending BLCO as a Sell, and 0 (0%) are recommending BLCO as a Strong Sell.

If you're new to stock investing, here's how to buy Bausch & Lomb stock.

What is BLCO's forecast return on equity (ROE) for 2023-2025?

(NYSE: BLCO) forecast ROE is 7.77%, which is considered weak.

What is BLCO's Price Target?

According to 5 Wall Street analysts that have issued a 1 year BLCO price target, the average BLCO price target is $19.40, with the highest BLCO stock price forecast at $22.00 and the lowest BLCO stock price forecast at $17.00.

On average, Wall Street analysts predict that Bausch & Lomb's share price could reach $19.40 by May 19, 2024. The average Bausch & Lomb stock price prediction forecasts a potential upside of 8.14% from the current BLCO share price of $17.94.

What is BLCO's forecast return on assets (ROA) for 2023-2025?

(NYSE: BLCO) forecast ROA is 4.86%, which is lower than the forecast US Medical Instruments & Supplies industry average of 10.78%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.